XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation
 9 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The following table summarizes stock-based compensation expense recognized in the condensed consolidated statements of operations: 
 Three Months Ended December 31,Nine Months Ended December 31,
 2022202120222021
Cost of revenue$9,091 $7,235 $26,227 $19,832 
General and administrative expenses9,679 9,524 24,765 25,355 
Total$18,770 $16,759 $50,992 $45,187 
The following table summarizes the total stock-based compensation expense recognized in the condensed consolidated statements of operations by the following types of equity awards, including stock options, time-based and performance-based restricted stock awards. Compensation expense for performance-based awards is estimated at each reporting date using management's expectation of the probable achievement of the specified performance criteria of each tranche during the respective performance periods:
 Three Months Ended December 31,Nine Months Ended December 31,
 2022202120222021
Equity Incentive Plan Options$772 $252 $2,005 $1,477 
Restricted Stock and other awards$17,998 16,507 48,987 43,710 
Total$18,770 $16,759 $50,992 $45,187 
As of December 31, 2022, there was $66.4 million of total unrecognized compensation cost related to unvested stock-based compensation agreements. The unrecognized compensation cost as of December 31, 2022 is expected to be fully amortized over the next 4.84 years. Absent the effect of accelerating stock compensation cost for any departures of employees who may continue to vest in their equity awards, the following table summarizes the unrecognized compensation cost and the weighted-average period the cost is expected to be amortized.
December 31, 2022
Unrecognized Compensation CostWeighted Average Remaining Period to be Recognized (in years)
Equity Incentive Plan Options$4,539 3.83
Restricted Stock Awards61,897 1.81
Total$66,436 
Equity Incentive Plan
As of December 31, 2022, there were 1.2 million EIP options outstanding, of which 0.6 million were unvested.
During the three months ended December 31, 2022, the Board of Directors granted 0.1 million restricted stock units to certain employees of the Company. The aggregate value of these awards was $15.0 million based on the grant date stock price.